Pegfilgrastim biosimilar - PfenexAlternative Names: PF-529
Latest Information Update: 09 Aug 2016
At a glance
- Originator Pfenex - Stelis Biopharma (JV)
- Developer Pfenex
- Class Chemoprotectants; Granulocyte colony-stimulating factors; Polyethylene glycols; Recombinant proteins
- Mechanism of Action Granulocyte stimulants; Haematopoietic cell growth factor stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Neutropenia